Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Liposomal Eribulin Mesylate

Known as: E7389 Liposomal Formulation, E7389-LF 
A liposome-encapsulated formulation of the mesylate salt form of eribulin, a synthetic, macrocyclic ketone analogue of halichondrin B, a substance… Expand
National Institutes of Health

Related topics

Related topics

4 relations
Microtubule ProcessMicrotubulesNegative Regulation of MitosisTubulin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Phase I study of liposomal formulation of eribulin (E7389-LF) in patients (pts) with advanced solid tumours: Primary results of dose-escalation part
Abstract Background Eribulin is approved for treatment of advanced/metastatic breast cancer and previously treated, unresected… Expand
2015
2015
Abstract 4543: Characterization of the liposomal formulation of eribulin mesylate (E7389) in mice
E7389 (eribulin mesylate, Halaven, Eisai) is a fully synthetic analog of the marine sponge natural product halichondrin B. It has… Expand
Review
2015
Review
2015
Eribulin in Cancer Treatment
Halichondrin B is a complex, natural, polyether macrolide derived from marine sponges. Eribulin is a structurally-simplified… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 3
2013
2013
Characterization of the pharmacokinetics of a liposomal formulation of eribulin mesylate (E7389) in mice.
Eribulin mesylate (E7389), a tubulin and microtubule inhibitor, has been approved to treat metastatic breast cancer in certain… Expand
Highly Cited
2009
Highly Cited
2009
New syntheses of E7389 C14-C35 and halichondrin C14-C38 building blocks: double-inversion approach.
With sequential use of catalytic asymmetric Cr-mediated coupling reactions, E7389 C14-C35 and halichondrin C14-C38 building… Expand
  • figure 1
2009
2009
New syntheses of E7389 C14-C35 and halichondrin C14-C38 building blocks: reductive cyclization and oxy-Michael cyclization approaches.
Cr-mediated coupling reactions are usually achieved with a slight excess of a given nucleophile. To develop a cost-effective use… Expand
2009
2009
Second generation synthesis of C27-C35 building block of E7389, a synthetic halichondrin analogue.
A practical method is reported to synthesize E7389 C27-C35 building block 13 from 1,2-O-isopropylidene-alpha-D-5-deoxyglucurono-6… Expand
  • figure 1
  • figure 2
2007
2007
Microtubule-Stabilizing Agent: Halichondrin B Analog (E7389)
The American Cancer Society projected that, in 2006, more than 212,000 cases of invasive breast cancer would be diagnosed and… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE